Selection of Active Drugs for Ovarian Cancer Based on CA-125 and Standard Response Rates in Phase II Trials (Q57618520)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | Selection of Active Drugs for Ovarian Cancer Based on CA-125 and Standard Response Rates in Phase II Trials |
article |
Statements
Selection of active drugs for ovarian cancer based on CA-125 and standard response rates in phase II trials (English)
G J Rustin
A E Nelstrop